← Leaderboards
Anne M Moon
University Of Utah
$8,563,327
Attributed
$8,563,327
Total exposure
5
Grants
4
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants. They are the sole PI on all grants (the two match).
Funding over time
peak $807.2K · FY2005–19$1M$750K$500K$250K$0
'05
'06
'07
'08
'09
'10
'11
'12
'13
'14
'15
'16
'17
'18
'19
Funding mix
By agency
NIH$8,563,327 · 5
By mechanism
R01$7,997,944 · 3
K08$404,190 · 1
R03$161,193 · 1
Top collaborators
No co-investigators on record.
Most similar at University Of Utah
Same institution · by research overlap
- Mario R Capecchi$17,194,081
- Teri J Mauch$1,696,837
Others in their field
Top investigators on “Mutant”
- Kc Kent Lloyd · University Of California At Davis$103,993,616
- Constance Ann Benson · University Of California, San Diego$65,790,143
- Bruce A Beutler · Ut Southwestern Medical Center$34,438,453
- Oscar A. Carretero · Henry Ford Health System$33,594,856
- Stuart H Orkin · Children'S Hospital Boston$33,454,343
- Tracy T Batchelor · Dana-Farber Cancer Inst$31,851,614
Research focus
MutantAllelesEmbryoMolecularTranscription FactorPhenotypeMesodermGene ExpressionPropertyCongenital AbnormalityIn VitroBaseIn VivoTissuesResearch StudyProgramsAblationPatternAffectSignal PathwayInvestigationPathway InteractionsDefectFibroblast Growth Factor
Grant awards (27)
Tbx3-regulated alternative RNA processing in cardiac conduction system development$522,342
R01 · FY2019 · HL · contact PI
Tbx3-regulated alternative RNA processing in cardiac conduction system development$639,876
R01 · FY2018 · HL · contact PI
Tbx3-regulated alternative RNA processing in cardiac conduction system development$663,127
R01 · FY2017 · HL · contact PI
Tbx3-regulated alternative RNA processing in cardiac conduction system development$747,785
R01 · FY2016 · HL · contact PI
The role of Fgf8 during cardiovascular development$305,990
R01 · FY2013 · HD · contact PI
The role of Fgf8 during cardiovascular development$322,435
R01 · FY2012 · HD · contact PI
Novel Tools for Detecting FGF8 for Developmental Biology Research$74,750
R03 · FY2012 · HD · contact PI
The role of Fgf8 during cardiovascular development$322,435
R01 · FY2011 · HD · contact PI
Novel Tools for Detecting FGF8 for Developmental Biology Research$86,443
R03 · FY2011 · HD · contact PI
The role of Fgf8 during cardiovascular development$309,165
R01 · FY2010 · HD · contact PI
Mutagenesis of Tbx3: a model of ulnar-mammary syndrome$92,141
R01 · FY2010 · HD · contact PI
Mutagenesis of Tbx3: a model of ulnar-mammary syndrome$312,566
R01 · FY2009 · HD · contact PI
The role of Fgf8 during cardiovascular development$312,288
R01 · FY2009 · HD · contact PI
The role of FGF8 during cardiovascular development$182,330
R01 · FY2009 · HD · contact PI
The role of FGF8 during cardiovascular development$312,566
R01 · FY2008 · HD · contact PI
Mutagenesis of Tbx3: a model of ulnar-mammary syndrome$312,566
R01 · FY2008 · HD · contact PI
Mutagenesis of Tbx3: a model of ulnar-mammary syndrome$318,945
R01 · FY2007 · HD · contact PI
The role of FGF8 during cardiovascular development$318,945
R01 · FY2007 · HD · contact PI
The role of FGF8 during cardiovascular development$328,471
R01 · FY2006 · HD · contact PI
Mutagenesis of Tbx3: a model of ulnar-mammary syndrome$328,471
R01 · FY2006 · HD · contact PI
The role of FGF8 during cardiovascular development$336,375
R01 · FY2005 · HD
Mutagenesis of Tbx3: a model of ulnar-mammary syndrome$336,375
R01 · FY2005 · HD
The role of FGF8 during cardiovascular development$336,375
R01 · FY2004 · HD
The role of FGF8 during cardiovascular development$336,375
R01 · FY2003 · HD
CONDITIONAL MUTAGENESIS OF FIBROBLAST GROWTH FACTORS$134,730
K08 · FY2002 · HD
CONDITIONAL MUTAGENESIS OF FIBROBLAST GROWTH FACTORS$134,730
K08 · FY2001 · HD
CONDITIONAL MUTAGENESIS OF FIBROBLAST GROWTH FACTORS$134,730
K08 · FY2000 · HD